The Russian Ministry of Health claims it will begin distributing vaccinations against cancer as soon as early 2025.

The global vaccine adjuvants market is anticipated to reach USD 0.96 billion by 2029 from USD 0.70 billion in 2024, with a ...

The virology market is projected to grow at a 5% CAGR from 2022 to 2032, reaching a valuation of US$ 3.53 billion by 2032.

Bicycle Therapeutics, a UK-headquartered pharma company developing a new class of therapeutics based on its proprietary bicyclic peptide technology, closed a third lower on Friday.

New research revealed tumor mutational burden was linked to improved event-free survival with pembrolizumab in early TNBC, ...

Senators Warren and Hawley seek to force vertically integrated healthcare conglomerates to divest their businesses operating ...

Pharmaceutical companies have an untapped potential to transform global health, but they cannot act alone. Governments, NGOs, ...

(RTTNews) - Merck & Co Inc. (MRK), Monday said China's National Medical Products Administration (NMPA) has approved Keytruda in combination with chemo therapy as neoadjuvant treatment, then as ...

Merck & Co – known as MSD outside of the US and Canada – has shared positive results from a late-stage trial of a Keytruda ...

Discover the latest advancements in small cell lung cancer through Novotech CRO’s in-depth disease analysis. Gain valuable insights into novel therapies, ongoing clinical trials, and future ...

Increasing prevalence of cardiovascular diseases and advancements in oncology therapies are driving growth in the global enzyme inhibitor market. Rising adoption of RNA-based inhibitors and small ...

DKSH has been appointed by MSD (Thailand) Ltd. to support its expansion efforts in Thailand. This collaboration aims to ...